G. Varrà

发表

Re-Definition of the Epidemiology of Cardiac Amyloidosis

G. Sinagra, M. Merlo, F. Dore, 2022, Biomedicines.

Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis

C. Autore, G. Barbati, C. Rapezzi, 2022, European journal of heart failure.

Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey

G. Parati, C. Autore, M. Metra, 2022, European journal of heart failure.

Grey zones in the supportive treatments of cardiac amyloidosis

C. Rapezzi, M. Merlo, A. Porcari, 2022, Vessel Plus.

Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy.

L. Mestroni, G. Barbati, G. Sinagra, 2021, The Canadian journal of cardiology.

Incidence and Characterization of Concealed Cardiac Amyloidosis Among Unselected Elderly Patients Undergoing Post-mortem Examination

G. Sinagra, M. Merlo, A. Porcari, 2021, Frontiers in Cardiovascular Medicine.

Evolving trends in epidemiology and natural history of cardiac amyloidosis: 30-year experience from a tertiary referral center for cardiomyopathies

G. Sinagra, M. Merlo, F. Dore, 2022, Frontiers in Cardiovascular Medicine.

Diagnostic pathways to wild‐type transthyretin amyloid cardiomyopathy: a multicentre network study

C. Mazzoni, C. Autore, M. Emdin, 2023, European journal of heart failure.

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study.

C. Autore, I. Olivotto, R. Pavasini, 2023, European journal of internal medicine.

Amyloidosis and Amyloidogenesis: One Name, Many Diseases.

M. Merlo, L. Pagura, G. Varrà, 2024, Heart failure clinics.